3.71
price down icon7.25%   -0.29
after-market Dopo l'orario di chiusura: 3.75 0.04 +1.08%
loading

Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
10.50%
71.15
64.39 69.42 73.71 67.38
Interest Income/Expense
0.21%
0.473
0.472 0.471 0.471 0.471
Operating Income/Loss
10.50%
-71.15
-64.39 -69.42 -73.71 -67.38
Income/Loss From Continuing Operations Before Tax
12.37%
-68.92
-61.33 -66.72 -69.65 -62.05
Income/Loss From Continuing Operations After Tax
12.37%
-68.92
-61.33 -66.72 -69.65 -62.05
Net Income/Loss
12.37%
-68.92
-61.33 -66.72 -69.65 -62.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.84%
111.02
110.09 94.16 93.75 93.55
Diluted Average Shares
0.84%
111.02
110.09 94.16 93.75 93.55
Basic Earnings Per Share
10.71%
-0.62
-0.56 -0.71 -0.74 -0.66
Diluted Earnings Per Share
10.71%
-0.62
-0.56 -0.71 -0.74 -0.66
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):